EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Association of Combined Iodine-125 Seed Implantation and Atezolizumab/Bevacizumab with Improved Outcomes in Recurrent Hepatocellular Carcinoma After Hepatectomy: A Comparative Retrospective Analysis

Jun Chen, Tianyou Shao iD, Bi Sheng

Journal of Hepatocellular Carcinoma · 2026-08 · Volume 13 · 1-13

DOI: 10.2147/jhc.s619755 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-08. Verfasst von Jun Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Wuhan Third Hospital, Wuhan, Hubei, 430060, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

atezolizumabbevacizumabhepatocellular carcinomaiodine-125 seedrecurrence

Autor:innen und Institutionen

  • Department of Pharmacy, Wuhan Third Hospital, Wuhan, Hubei, 430060, People's Republic of China.
  • Department of interventional vascular, Jiang Xi Province Chest Hospital, Nanchang, Jiangxi, 330006, People's Republic of China.

ORCID-Profile: Tianyou Shao

Zitieren

APA

Chen, J., Shao, T., & Sheng, B. (2026). Association of Combined Iodine-125 Seed Implantation and Atezolizumab/Bevacizumab with Improved Outcomes in Recurrent Hepatocellular Carcinoma After Hepatectomy: A Comparative Retrospective Analysis. Journal of Hepatocellular Carcinoma, Volume 13, 1-13. https://doi.org/10.2147/jhc.s619755

Vancouver

Chen J, Shao T, Sheng B. Association of Combined Iodine-125 Seed Implantation and Atezolizumab/Bevacizumab with Improved Outcomes in Recurrent Hepatocellular Carcinoma After Hepatectomy: A Comparative Retrospective Analysis. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-13. doi:10.2147/jhc.s619755

BibTeX
@article{Chen2026,
  author = {Chen, Jun and Shao, Tianyou and Sheng, Bi},
  title = {Association of Combined Iodine-125 Seed Implantation and Atezolizumab/Bevacizumab with Improved Outcomes in Recurrent Hepatocellular Carcinoma After Hepatectomy: A Comparative Retrospective Analysis},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2026},
  volume = {Volume 13},
  pages = {1--13},
  doi = {10.2147/jhc.s619755}
}
Kostenlos starten →